“Incipient” Primary Hyperparathyroidism: A “Forme Fruste” of an Old Disease
Open Access
- 1 November 2003
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 88 (11) , 5348-5352
Abstract
Although primary hyperparathyroidism today is often a relatively asymptomatic disease, it has distinct biochemical and skeletal features. These features are present at diagnosis and are generally stable over time, leading to the theory of a biphasic disease course in which alterations occur during a preclinical phase. Measurement of calciotropic hormones in individuals undergoing skeletal evaluation has led to the identification of normocalcemic individuals with elevated PTH levels. We hypothesize that these patients represent the earliest manifestations of primary hyperparathyroidism Twenty-two patients had hyperparathyroidism (94 ± 29 pg/ml) and normal corrected serum calcium levels (2.40 ± 0.02 mmol/liter). No secondary causes of hyperparathyroidism were found. PTH levels did not correlate with urinary calcium concentration, renal function, vitamin D concentrations, or bone density. The relationship between PTH and serum calcium (regression slope, +0.004) was identical in normocalcemic and hypercalcemic hyperparathyroid patients. Preferential cortical bone loss, characteristic of patients with primary hyperparathyroidism, was not seen (T-score: spine, −1.6; hip, −1.8; distal one-third radius, −1.3). In up to 12 months of observation, three patients have developed hypercalcemia, and one has had two adenomas removed. These patients with elevated PTH levels in the absence of hypercalcemia may provide a window into this previously unrecognized stage of the disease and permit investigators to track its evolution in ways that have not heretofore been possible.Keywords
This publication has 10 references indexed in Scilit:
- Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1–84) in Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2003
- Synthetic Carboxyl-Terminal Fragments of Parathyroid Hormone (PTH) Decrease Ionized Calcium Concentration in Rats by Acting on a Receptor Different from the PTH/PTH-Related Peptide ReceptorEndocrinology, 2001
- Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid FunctionJournal of Bone and Mineral Research, 2001
- A novel mechanism for skeletal resistance in uremiaKidney International, 2000
- A Novel Immunoradiometric Assay Detects Full-Length Human PTH but not Amino-Terminally Truncated Fragments: Implications for PTH Measurements in Renal FailureThe Journal of Clinical Endocrinology & Metabolism, 1999
- A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid SurgeryNew England Journal of Medicine, 1999
- A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samplesClinical Chemistry, 1998
- Hypovitaminosis D in Medical InpatientsNew England Journal of Medicine, 1998
- Skeletal disease in primary hyperparathyroidismJournal of Bone and Mineral Research, 1989
- Lack of Biochemical Progression or Continuation of Accelerated Bone Loss in Mild Asymptomatic Primary Hyperparathyroidism: Evidence for Biphasic Disease CourseThe Journal of Clinical Endocrinology & Metabolism, 1988